Skip to content

Effects of Shatavhadi Yog Basti in the Management of Amavata

Clinical Efficacy of Shatavhadi Yog Basti in the Management of Amavata

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053413
Enrollment
38
Registered
2023-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Tilak Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between 18 to 60 years of age of either sex with clinical features of amavata mentioned in ayurvedic samhita i.e. Sandhishool, Sandhishotha, Sandhistabdhata, Sparshasahyatwa, Sandhi aushnya, Jwar and those who fulfill the - 2010: ACR and EULAR revised classification criteria for rheumatoid arthritis(18) are to be selected for the proposed study. Application of the newly revised criteria yields a score of 0-10. Those with the score > 6 fulfill the requirements for definite RA and a criterion for enrollment as a participant.

Exclusion criteria

Exclusion criteria: Chronicity of more than 5 years. Having severe crippling deformity. Patients having neoplasm of spine, gout, ankylosing spondylitis, traumatic arthritis, and pyogenic osteomyelitis. Having cardiac disease, pulmonary tuberculosis and renal function impairment, diabetes mellitus and malignant hypertension. Pregnant women and lactating mother. Patients contraindicated for basti as mentioned in ayurvedic samhita.

Design outcomes

Primary

MeasureTime frame
1.Signs and symptoms of amavata (RA) | Subjective parameters a.Sandhishool (Pain) b.Sandhishotha (Swelling) c.Sandhistabdhata (Stiffness) d.Sparshasahyatwa (Tenderness) e.Sandhi aushnya (Warmth) f.Jwar (Fever) Timepoint: Day 1, Day 8, Day 14 and Day 21

Secondary

MeasureTime frame
a. Serology : ESR and CRP b. Acute phase reactants : RF and ACPA Timepoint: Day 1 and Day 21

Countries

India

Contacts

Public ContactDr Rajendra S Huparikar

Tilak Ayurved Mahavidyalaya

ayurvedapune@gmail.com9823050402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026